Industry: Service & Software
Published Date: 2025-03-11
Pages: 113 Pages
Report ld: 4638862
Request Sample
Customized Report
The global market for Medical Device Pyrogenicity Testing Service was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
North American market for Medical Device Pyrogenicity Testing Service was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Medical Device Pyrogenicity Testing Service was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Medical Device Pyrogenicity Testing Service was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global key companies of Medical Device Pyrogenicity Testing Service include Eurofins, Nelson Laboratories, Pacific BioLabs, GenScript, SGS, Sartorius AG, Iuvo, Microcoat, Measurlabs, Charles River, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Medical Device Pyrogenicity Testing Service, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Medical Device Pyrogenicity Testing Service by region & country, by Type, and by Application.
The Medical Device Pyrogenicity Testing Service market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Device Pyrogenicity Testing Service.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Medical Device Pyrogenicity Testing Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Medical Device Pyrogenicity Testing Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Medical Device Pyrogenicity Testing Service in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Medical Device Pyrogenicity Testing Service Product Introduction
1.2 Global Medical Device Pyrogenicity Testing Service Market Size Forecast (2020-2031)
1.3 Medical Device Pyrogenicity Testing Service Market Trends & Drivers
1.3.1 Medical Device Pyrogenicity Testing Service Industry Trends
1.3.2 Medical Device Pyrogenicity Testing Service Market Drivers & Opportunity
1.3.3 Medical Device Pyrogenicity Testing Service Market Challenges
1.3.4 Medical Device Pyrogenicity Testing Service Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Medical Device Pyrogenicity Testing Service Players Revenue Ranking (2024)
2.2 Global Medical Device Pyrogenicity Testing Service Revenue by Company (2020-2025)
2.3 Key Companies Medical Device Pyrogenicity Testing Service Manufacturing Base Distribution and Headquarters
2.4 Key Companies Medical Device Pyrogenicity Testing Service Product Offered
2.5 Key Companies Time to Begin Mass Production of Medical Device Pyrogenicity Testing Service
2.6 Medical Device Pyrogenicity Testing Service Market Competitive Analysis
2.6.1 Medical Device Pyrogenicity Testing Service Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by Medical Device Pyrogenicity Testing Service Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Device Pyrogenicity Testing Service as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Bacterial Endotoxin Testing
3.1.2 Monocyte Activation Testing
3.1.3 Others
3.2 Global Medical Device Pyrogenicity Testing Service Sales Value by Type
3.2.1 Global Medical Device Pyrogenicity Testing Service Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Medical Device Pyrogenicity Testing Service Sales Value, by Type (2020-2031)
3.2.3 Global Medical Device Pyrogenicity Testing Service Sales Value, by Type (%) (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Implantable Devices
4.1.2 Blood-Contacting Devices
4.1.3 Others
4.2 Global Medical Device Pyrogenicity Testing Service Sales Value by Application
4.2.1 Global Medical Device Pyrogenicity Testing Service Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Medical Device Pyrogenicity Testing Service Sales Value, by Application (2020-2031)
4.2.3 Global Medical Device Pyrogenicity Testing Service Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
5.1 Global Medical Device Pyrogenicity Testing Service Sales Value by Region
5.1.1 Global Medical Device Pyrogenicity Testing Service Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Medical Device Pyrogenicity Testing Service Sales Value by Region (2020-2025)
5.1.3 Global Medical Device Pyrogenicity Testing Service Sales Value by Region (2026-2031)
5.1.4 Global Medical Device Pyrogenicity Testing Service Sales Value by Region (%), (2020-2031)
5.2 North America
5.2.1 North America Medical Device Pyrogenicity Testing Service Sales Value, 2020-2031
5.2.2 North America Medical Device Pyrogenicity Testing Service Sales Value by Country (%), 2024 VS 2031
5.3 Europe
5.3.1 Europe Medical Device Pyrogenicity Testing Service Sales Value, 2020-2031
5.3.2 Europe Medical Device Pyrogenicity Testing Service Sales Value by Country (%), 2024 VS 2031
5.4 Asia Pacific
5.4.1 Asia Pacific Medical Device Pyrogenicity Testing Service Sales Value, 2020-2031
5.4.2 Asia Pacific Medical Device Pyrogenicity Testing Service Sales Value by Region (%), 2024 VS 2031
5.5 South America
5.5.1 South America Medical Device Pyrogenicity Testing Service Sales Value, 2020-2031
5.5.2 South America Medical Device Pyrogenicity Testing Service Sales Value by Country (%), 2024 VS 2031
5.6 Middle East & Africa
5.6.1 Middle East & Africa Medical Device Pyrogenicity Testing Service Sales Value, 2020-2031
5.6.2 Middle East & Africa Medical Device Pyrogenicity Testing Service Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Medical Device Pyrogenicity Testing Service Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Medical Device Pyrogenicity Testing Service Sales Value, 2020-2031
6.3 United States
6.3.1 United States Medical Device Pyrogenicity Testing Service Sales Value, 2020-2031
6.3.2 United States Medical Device Pyrogenicity Testing Service Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Medical Device Pyrogenicity Testing Service Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Medical Device Pyrogenicity Testing Service Sales Value, 2020-2031
6.4.2 Europe Medical Device Pyrogenicity Testing Service Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Medical Device Pyrogenicity Testing Service Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Medical Device Pyrogenicity Testing Service Sales Value, 2020-2031
6.5.2 China Medical Device Pyrogenicity Testing Service Sales Value by Type (%), 2024 VS 2031
6.5.3 China Medical Device Pyrogenicity Testing Service Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Medical Device Pyrogenicity Testing Service Sales Value, 2020-2031
6.6.2 Japan Medical Device Pyrogenicity Testing Service Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Medical Device Pyrogenicity Testing Service Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Medical Device Pyrogenicity Testing Service Sales Value, 2020-2031
6.7.2 South Korea Medical Device Pyrogenicity Testing Service Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Medical Device Pyrogenicity Testing Service Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Medical Device Pyrogenicity Testing Service Sales Value, 2020-2031
6.8.2 Southeast Asia Medical Device Pyrogenicity Testing Service Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Medical Device Pyrogenicity Testing Service Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Medical Device Pyrogenicity Testing Service Sales Value, 2020-2031
6.9.2 India Medical Device Pyrogenicity Testing Service Sales Value by Type (%), 2024 VS 2031
6.9.3 India Medical Device Pyrogenicity Testing Service Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Eurofins
7.1.1 Eurofins Profile
7.1.2 Eurofins Main Business
7.1.3 Eurofins Medical Device Pyrogenicity Testing Service Products, Services and Solutions
7.1.4 Eurofins Medical Device Pyrogenicity Testing Service Revenue (US$ Million) & (2020-2025)
7.1.5 Eurofins Recent Developments
7.2 Nelson Laboratories
7.2.1 Nelson Laboratories Profile
7.2.2 Nelson Laboratories Main Business
7.2.3 Nelson Laboratories Medical Device Pyrogenicity Testing Service Products, Services and Solutions
7.2.4 Nelson Laboratories Medical Device Pyrogenicity Testing Service Revenue (US$ Million) & (2020-2025)
7.2.5 Nelson Laboratories Recent Developments
7.3 Pacific BioLabs
7.3.1 Pacific BioLabs Profile
7.3.2 Pacific BioLabs Main Business
7.3.3 Pacific BioLabs Medical Device Pyrogenicity Testing Service Products, Services and Solutions
7.3.4 Pacific BioLabs Medical Device Pyrogenicity Testing Service Revenue (US$ Million) & (2020-2025)
7.3.5 Pacific BioLabs Recent Developments
7.4 GenScript
7.4.1 GenScript Profile
7.4.2 GenScript Main Business
7.4.3 GenScript Medical Device Pyrogenicity Testing Service Products, Services and Solutions
7.4.4 GenScript Medical Device Pyrogenicity Testing Service Revenue (US$ Million) & (2020-2025)
7.4.5 GenScript Recent Developments
7.5 SGS
7.5.1 SGS Profile
7.5.2 SGS Main Business
7.5.3 SGS Medical Device Pyrogenicity Testing Service Products, Services and Solutions
7.5.4 SGS Medical Device Pyrogenicity Testing Service Revenue (US$ Million) & (2020-2025)
7.5.5 SGS Recent Developments
7.6 Sartorius AG
7.6.1 Sartorius AG Profile
7.6.2 Sartorius AG Main Business
7.6.3 Sartorius AG Medical Device Pyrogenicity Testing Service Products, Services and Solutions
7.6.4 Sartorius AG Medical Device Pyrogenicity Testing Service Revenue (US$ Million) & (2020-2025)
7.6.5 Sartorius AG Recent Developments
7.7 Iuvo
7.7.1 Iuvo Profile
7.7.2 Iuvo Main Business
7.7.3 Iuvo Medical Device Pyrogenicity Testing Service Products, Services and Solutions
7.7.4 Iuvo Medical Device Pyrogenicity Testing Service Revenue (US$ Million) & (2020-2025)
7.7.5 Iuvo Recent Developments
7.8 Microcoat
7.8.1 Microcoat Profile
7.8.2 Microcoat Main Business
7.8.3 Microcoat Medical Device Pyrogenicity Testing Service Products, Services and Solutions
7.8.4 Microcoat Medical Device Pyrogenicity Testing Service Revenue (US$ Million) & (2020-2025)
7.8.5 Microcoat Recent Developments
7.9 Measurlabs
7.9.1 Measurlabs Profile
7.9.2 Measurlabs Main Business
7.9.3 Measurlabs Medical Device Pyrogenicity Testing Service Products, Services and Solutions
7.9.4 Measurlabs Medical Device Pyrogenicity Testing Service Revenue (US$ Million) & (2020-2025)
7.9.5 Measurlabs Recent Developments
7.10 Charles River
7.10.1 Charles River Profile
7.10.2 Charles River Main Business
7.10.3 Charles River Medical Device Pyrogenicity Testing Service Products, Services and Solutions
7.10.4 Charles River Medical Device Pyrogenicity Testing Service Revenue (US$ Million) & (2020-2025)
7.10.5 Charles River Recent Developments
7.11 TUV SUD
7.11.1 TUV SUD Profile
7.11.2 TUV SUD Main Business
7.11.3 TUV SUD Medical Device Pyrogenicity Testing Service Products, Services and Solutions
7.11.4 TUV SUD Medical Device Pyrogenicity Testing Service Revenue (US$ Million) & (2020-2025)
7.11.5 TUV SUD Recent Developments
7.12 MAT Research
7.12.1 MAT Research Profile
7.12.2 MAT Research Main Business
7.12.3 MAT Research Medical Device Pyrogenicity Testing Service Products, Services and Solutions
7.12.4 MAT Research Medical Device Pyrogenicity Testing Service Revenue (US$ Million) & (2020-2025)
7.12.5 MAT Research Recent Developments
7.13 Ethide Labs
7.13.1 Ethide Labs Profile
7.13.2 Ethide Labs Main Business
7.13.3 Ethide Labs Medical Device Pyrogenicity Testing Service Products, Services and Solutions
7.13.4 Ethide Labs Medical Device Pyrogenicity Testing Service Revenue (US$ Million) & (2020-2025)
7.13.5 Ethide Labs Recent Developments
7.14 Wickham Micro
7.14.1 Wickham Micro Profile
7.14.2 Wickham Micro Main Business
7.14.3 Wickham Micro Medical Device Pyrogenicity Testing Service Products, Services and Solutions
7.14.4 Wickham Micro Medical Device Pyrogenicity Testing Service Revenue (US$ Million) & (2020-2025)
7.14.5 Wickham Micro Recent Developments
8 Industry Chain Analysis
8.1 Medical Device Pyrogenicity Testing Service Industrial Chain
8.2 Medical Device Pyrogenicity Testing Service Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Medical Device Pyrogenicity Testing Service Sales Model
8.5.2 Sales Channel
8.5.3 Medical Device Pyrogenicity Testing Service Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Medical Device Pyrogenicity Testing Service market is projected to grow from US$ 162 million in 2025 to US$ 242 million by 2032, at a CAGR of 5.8% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-06-04
Pages: 158
USD 4900.00
(Single User License)
The global Medical Device Pyrogenicity Testing Service market size was US$ 162 million in 2025 and is forecast to reach a readjusted size of US$ 242 million by 2032 with a CAGR of 5.8% during the forecast period 2026-2032.
Published Date: 2026-06-04
Pages: 132
USD 4250.00
(Single User License)
The global market for Medical Device Pyrogenicity Testing Service was estimated to be worth US$ 162 million in 2025 and is projected to reach US$ 242 million, growing at a CAGR of 5.8% from 2026 to 2032.
Published Date: 2026-06-04
Pages: 132
USD 3950.00
(Single User License)
The global Medical Device Pyrogenicity Testing Service market was valued at US$ 162 million in 2025 and is anticipated to reach US$ 242 million by 2032, at a CAGR of 5.8% from 2026 to 2032.
Published Date: 2026-06-04
Pages: 135
USD 2900.00
(Single User License)
The global Medical Device Pyrogenicity Testing Service market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 91
USD 4250.00
(Single User License)
The global Medical Device Pyrogenicity Testing Service market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-05
Pages: 139
USD 4900.00
(Single User License)
The global market for Medical Device Pyrogenicity Testing Service was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-11
Pages: 84
USD 2900.00
(Single User License)
The global Medical Device Pyrogenicity Testing Service market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published Date: 2024-04-07
Pages: 145
USD 4900.00
(Single User License)
The global Medical Device Pyrogenicity Testing Service revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
Published Date: 2024-04-07
Pages: 108
USD 4350.00
(Single User License)
The global market for Medical Device Pyrogenicity Testing Service was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the forecast period 2024-2030.
Published Date: 2024-04-07
Pages: 116
USD 3950.00
(Single User License)
The global Medical Device Pyrogenicity Testing Service market is projected to grow from US$ 162 million in 2025 to US$ 242 million by 2032, at a CAGR of 5.8% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-06-04
Pages: 158
The global Medical Device Pyrogenicity Testing Service market size was US$ 162 million in 2025 and is forecast to reach a readjusted size of US$ 242 million by 2032 with a CAGR of 5.8% during the forecast period 2026-2032.
Published: 2026-06-04
Pages: 132
The global market for Medical Device Pyrogenicity Testing Service was estimated to be worth US$ 162 million in 2025 and is projected to reach US$ 242 million, growing at a CAGR of 5.8% from 2026 to 2032.
Published: 2026-06-04
Pages: 132
The global Medical Device Pyrogenicity Testing Service market was valued at US$ 162 million in 2025 and is anticipated to reach US$ 242 million by 2032, at a CAGR of 5.8% from 2026 to 2032.
Published: 2026-06-04
Pages: 135
The global Medical Device Pyrogenicity Testing Service market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 91
The global Medical Device Pyrogenicity Testing Service market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-05
Pages: 139
The global market for Medical Device Pyrogenicity Testing Service was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-11
Pages: 84
The global Medical Device Pyrogenicity Testing Service market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published: 2024-04-07
Pages: 145
The global Medical Device Pyrogenicity Testing Service revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
Published: 2024-04-07
Pages: 108
The global market for Medical Device Pyrogenicity Testing Service was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the forecast period 2024-2030.
Published: 2024-04-07
Pages: 116
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now